Security key
59102M104
- Type / Class
- Equity / COM
- Total 13F shares
- 6,463,712
- Share change
- -271,764
- Total reported value
- $8,651,563
- Price per share
- $1.34
- Number of holders
- 47
- Value change
- -$474,616
- Number of buys
- 11
- Number of sells
- 26
Report period
Q1 2026
Institutions
47
Top holders
10
MGX full security history
Previous quarter: Q4 2025
Metagenomi Therapeutics, Inc. SEC filings
Metagenomi Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 59102M104
Recent filing periods:
Top shareholders of MGX - Metagenomi Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAYER HEALTHCARE LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,050,997
|
$11,666,871 | — | 13 Feb 2024 | |
| Novo Holdings A/S |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,739,175
|
$5,008,824 | — | 09 Feb 2024 | |
| Sebastian Bernales |
3/4/5
|
Director |
—
mixed-class rows
|
3,147,422
mixed-class rows
|
$6,620,950 | — | 01 Apr 2024 | |
| Brian C. Thomas |
3/4/5
|
Director |
—
mixed-class rows
|
2,706,960
mixed-class rows
|
$4,449,170 | -$30,549 | 05 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
class O/S missing
|
1,270,246
|
$2,057,799 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
—
class O/S missing
|
628,400
|
$1,018,008 | — | 31 Dec 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
—
class O/S missing
|
528,993
|
$856,969 | — | 31 Dec 2025 | |
| Peapod Lane Capital LLC |
13F
|
Company |
—
class O/S missing
|
497,653
|
$806,198 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
—
class O/S missing
|
441,388
|
$715,049 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
—
class O/S missing
|
433,859
|
$702,851 | — | 31 Dec 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
395,800
|
$641,196 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
305,908
|
$495,765 | — | 31 Dec 2025 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
—
class O/S missing
|
264,391
|
$428,313 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
235,185
|
$381,000 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
—
class O/S missing
|
224,141
|
$363,108 | — | 31 Dec 2025 | |
| Simon Harnest |
3/4/5
|
Title: Chief Investment Officer and Senior Vice President of Strategy |
—
mixed-class rows
|
171,239
mixed-class rows
|
$353,272 | — | 01 Apr 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
—
class O/S missing
|
201,300
|
$326,106 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
178,172
|
$288,638 | — | 31 Dec 2025 | |
| Simren Delaney |
3/4/5
|
Title: Vice President of Intellectual Property and Legal Operations |
—
mixed-class rows
|
123,037
mixed-class rows
|
$270,409 | — | 01 Apr 2024 | |
| Luis Borges |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
360,766
mixed-class rows
|
$199,630 | — | 01 Apr 2024 | |
| STATE STREET CORP |
13F
|
Company |
—
class O/S missing
|
120,427
|
$195,092 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
—
class O/S missing
|
118,410
|
$191,824 | — | 31 Dec 2025 | |
| Sarah B. Noonberg |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
193,135
mixed-class rows
|
$190,986 | -$9,168 | 06 Jun 2025 | |
| Resolute Advisors LLC |
13F
|
Company |
—
class O/S missing
|
89,944
|
$145,709 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
—
class O/S missing
|
79,136
|
$128,200 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
—
class O/S missing
|
75,172
|
$121,779 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
—
class O/S missing
|
68,994
|
$111,770 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
64,875
|
$105,000 | — | 31 Dec 2025 | |
| RBF Capital, LLC |
13F
|
Company |
—
class O/S missing
|
64,021
|
$103,714 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
—
class O/S missing
|
59,682
|
$96,685 | — | 31 Dec 2025 | |
| Man Group plc |
13F
|
Company |
—
class O/S missing
|
56,497
|
$91,525 | — | 31 Dec 2025 | |
| BBR PARTNERS, LLC |
13F
|
Company |
—
class O/S missing
|
53,403
|
$86,513 | — | 31 Dec 2025 | |
| Fortitude Advisory Group L.L.C. |
13F
|
Company |
—
class O/S missing
|
38,740
|
$62,759 | — | 31 Dec 2025 | |
| Quadrature Capital Ltd |
13F
|
Company |
—
class O/S missing
|
33,917
|
$54,946 | — | 31 Dec 2025 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
—
class O/S missing
|
32,580
|
$52,780 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
—
class O/S missing
|
26,589
|
$43,074 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
25,099
|
$40,660 | — | 31 Dec 2025 | |
| Dynamic Technology Lab Private Ltd |
13F
|
Company |
—
class O/S missing
|
23,762
|
$38,000 | — | 31 Dec 2025 | |
| Vanguard Personalized Indexing Management, LLC |
13F
|
Company |
—
class O/S missing
|
16,298
|
$26,403 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
—
class O/S missing
|
13,783
|
$22,328 | — | 31 Dec 2025 | |
| Peak Planning Group, LLC |
13F
|
Company |
—
class O/S missing
|
12,500
|
$20,250 | — | 31 Dec 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
—
class O/S missing
|
11,700
|
$18,954 | — | 31 Dec 2025 | |
| LPL Financial LLC |
13F
|
Company |
—
class O/S missing
|
11,297
|
$18,301 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
—
class O/S missing
|
10,594
|
$17,162 | — | 31 Dec 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
—
class O/S missing
|
11,091
|
$17,000 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
9,303
|
$15,071 | — | 31 Dec 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
—
class O/S missing
|
7,136
|
$11,560 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
—
class O/S missing
|
6,808
|
$11,029 | — | 31 Dec 2025 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
—
class O/S missing
|
5,496
|
$8,904 | — | 31 Dec 2025 | |
| US BANCORP \DE\ |
13F
|
Company |
—
class O/S missing
|
4,500
|
$7,290 | — | 31 Dec 2025 |
Institutional Holders of Metagenomi Therapeutics, Inc. - COM (MGX) as of Q1 2026
As of 31 Mar 2026,
Metagenomi Therapeutics, Inc. - COM (MGX) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,463,712 shares.
The largest 10 holders included
VANGUARD CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, Catalio Capital Management, LP, Peapod Lane Capital LLC, TWO SIGMA INVESTMENTS, LP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, GEODE CAPITAL MANAGEMENT, LLC, PURA VIDA INVESTMENTS, LLC, and BlackRock, Inc..
This page lists
47
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
54
Q1 2026 holders
47
Holder diff
-7
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.